Have a question or need more info? Fill out the form and we'll get back to you soon.
May 16, 2025
In a landmark initiative to advance psychiatric and neurological care across India, Aerobe and MagVenture joined forces for a transformative week of knowledge-sharing and hands-on training. From April 10th to 16th, 2025, our team embarked on a multi-city tour, connecting with leading clinicians and researchers to explore the power of repetitive Transcranial Magnetic Stimulation (rTMS) enhanced by precision Neuronavigation.
This was more than a roadshow; it was a mission to empower India's medical community with the tools and techniques shaping the future of brain health.
The initiative kicked off in the nation's capital, focusing on institutions at the forefront of medical research and patient care. In-depth dialogues with Dr. Renu Bhatia and Dr. Ashok J at AIIMS Delhi explored the vast therapeutic potential of MagVenture's psychiatric applications.
The journey culminated at Medanta Hospital, Gurugram, where a final presentation and intensive training session led by MagVenture's expert, Eddie, provided clinicians with a deep dive into the practical application of rTMS with neuronavigation.
The tour's Hyderabad leg was a testament to the city's burgeoning role as a healthcare hub. The team engaged with specialists across three leading hospitals in a single day:
A pivotal moment of the initiative was the visit to GITAM University in Vizag. By bringing a comprehensive rTMS with neuronavigation training session directly to an academic setting, the mission invested in the future, providing students and faculty with invaluable exposure to world-class technology and pioneering treatment methodologies.
This collaborative effort between Aerobe and MagVenture has ignited crucial conversations and laid a strong foundation for the wider adoption of advanced neuromodulation in India. By bringing this technology directly to the clinicians who will use it to transform patient lives, we are not just presenting a product; we are helping to build a new standard of care in psychiatry and neuroscience.